Burrill & Company

Burrill & Company operates as a diversified financial services firm, specializing in the life sciences industry. The firm provides venture capital and private equity investments, primarily targeting companies in biotechnology, pharmaceuticals, medical devices, and human healthcare. Additionally, it offers comprehensive financial advisory services, including support for mergers and acquisitions, divestitures, and reverse mergers, catering to the unique transactional needs of its specialized client base. The company’s approach integrates deep industry knowledge with financial expertise to support growth and strategic development within the sector.

G. Steven Burrill founded Burrill & Company in 1994, establishing its headquarters in San Francisco, California. His vision was to create a focused private merchant bank dedicated exclusively to the burgeoning life science sector. This strategic insight recognized the substantial capital requirements and specialized investment landscape inherent to biotechnological and healthcare innovation, positioning the firm to become a significant player in financing and advising scientific breakthroughs.

The firm's clients primarily include private and public companies across the biotechnology, pharmaceutical, and healthcare domains, from early-stage startups to established enterprises. Burrill & Company’s overarching vision centers on fostering advancements that drive progress in global health and agricultural biotechnology. By providing essential capital and strategic guidance, the firm aims to accelerate the development and commercialization of critical innovations that address unmet needs and improve quality of life worldwide.